Quick Answer
Centessa Pharmaceuticals plc reported Common Stock Shares Outstanding of 149.23 million shares for the year ending 2025.
- Centessa Pharmaceuticals plc showed an increase of +12.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Centessa Pharmaceuticals plc's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: 89.90 million shares | Q3 2021: 89.90 million shares | Q1 2022: 94.02 million shares | Q2 2022: 94.27 million shares | Q3 2022: 94.57 million shares | Q1 2023: 95.10 million shares | Q2 2023: 95.30 million shares | Q3 2023: 97.57 million shares | Q1 2024: 100.48 million shares | Q2 2024: 113.18 million shares | Q3 2024: 131.66 million shares | Q1 2025: 133.55 million shares | Q2 2025: 133.91 million shares | Q3 2025: 134.42 million shares.
- Historical annual values: Fiscal year 2025: 149.23 million shares | Fiscal year 2024: 132.63 million shares | Fiscal year 2023: 98.77 million shares | Fiscal year 2022: 94.84 million shares | Fiscal year 2021: 89.99 million shares | Fiscal year 2020: 0 shares.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: